FDA Revokes Approval Of Breast Cancer Drug AvastinAvastin for breast cancer is out. The FDA says the drug should no longer be used for breast cancer because there's no proof it extends patients' lives - and it causes dangerous side effects.
FDA Panel Votes Against Breast Cancer DrugFive randomized controlled trials of 3,500 patients showed no significant improvement in overall survival or quality of life. There's also an increased risk of ruptured intestines, bleeding and death.
Bringing You The Best in Sports Talk Radio
Download And Win Today!

Listen Live